BioCentury
ARTICLE | Company News

Flamel, Theralpha deal

May 16, 2011 7:00 AM UTC

The companies partnered to co-develop a controlled-release formulation of Theralpha's THA902 to treat pain. Flamel will contribute its Medusa nanogel polymer drug delivery technology, while Theralpha...